Onderneming Boston Therapeutics, Inc. Other OTC
Aandelen
BTHE
US1011501004
Geavanceerde medische apparatuur & technologie
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Ludvigson
CEO | Chief Executive Officer | 74 | - |
Director of Finance/CFO | - | 19-01-23 | |
Bradley Johnson
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-22 |
Vidur Sahney
COO | Chief Operating Officer | - | 31-03-22 |
John Hardesky
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jerry Fiddler
BRD | Director/Board Member | 72 | - |
Chairman | 69 | - | |
David Ludvigson
CEO | Chief Executive Officer | 74 | - |
Director/Board Member | 67 | - | |
Tadd Lazarus
BRD | Director/Board Member | - | 31-08-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 540 | 0 | 0 | 42,05 % |
Aandeel B | 0 | 377 | 0 | 0 | |
Aandeel C | 1 | 48 996 763 | 20 604 326 ( 42,05 %) | 0 |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,63% | 8,68 mld. | |
+38,91% | 4,56 mld. | |
-30,18% | 2,72 mld. | |
-9,44% | 1,61 mld. | |
-21,71% | 1,34 mld. | |
-37,12% | 1,08 mld. | |
+2,76% | 929 mln. | |
-42,75% | 791 mln. | |
-23,56% | 675 mln. |